Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin
Michael A. Nauck(Katholisches Klinikum Bochum), Shamik Parikh(Humacyte (United States))
Cited by 529
Related Papers
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
|Diabetes Care|2021|417